Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted epoxyeicosatrienoic acid (EET) analogs for treatment of kidney disease

Substituted epoxyeicosatrienoic acid (EET) analogs for treatment of kidney disease

US Patent 11358968 · Granted Jun 14, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of manufacturing 14,15-epoxyeicosatrienoic acid analogs and improved the2024
20-HETE receptor (GPR75) antagonists and methods of use2023
Diabetes and metabolic syndrome treatment with a novel dual modulator of soluble2022
Eicosanoid derivatives2022
CYP-eicosanoid derivatives2021
Metabolically robust analogs of CYP-eicosanoids for the treatment of cardiac dis2021
Direct C—H amination and aza-annulation2021
Compositions and methods for delivery of polyunsaturated fatty acid derivatives 2021
Diabetes and metabolic syndrome treatment with a novel dual modulator of soluble2021
Eicosanoid derivatives2019
Direct stereospecific synthesis of unprotected aziridines from olefins2018
Methods for modulating bacterial virulence and related compounds2017